Telehealth has become a major source of healthcare during the Covid-19 pandemic, accounting for around 5 percent of all health insurance claims, primarily for behavioral health. However, geographical distance between patient, provider and pharmacist continues to create obstacles, especially with regard to prescriptions for controlled substances. The upcoming rules from the U.S. Drug Enforcement Administration (DEA) could potentially heighten these barriers. The ATA suggests creating a Special Registration process for remote prescribing of controlled substances to ensure prescriptions are legitimate, and a safe harbor for pharmacists dispensing remote prescriptions.
Cell Signaling-Inspired DNA Sensor Enables Molecular Detection from Single Blood Drop
Drawing inspiration from natural cell signaling cascades, chemists at Université de Montréal (UdeM) have developed a DNA-based signaling cascade that allows them to quantify and
